Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Semaglutide	21
Overall Study	STARTED	Semaglutide + Firsocostat 20 mg	22
Overall Study	STARTED	Semaglutide + Cilofexor 30 mg	22
Overall Study	STARTED	Semaglutide + Cilofexor 100 mg	22
Overall Study	STARTED	Semaglutide + Firsocostat 20 mg + Cilofexor 30 mg	21
Overall Study	COMPLETED	Semaglutide	18
Overall Study	COMPLETED	Semaglutide + Firsocostat 20 mg	20
Overall Study	COMPLETED	Semaglutide + Cilofexor 30 mg	21
Overall Study	COMPLETED	Semaglutide + Cilofexor 100 mg	18
Overall Study	COMPLETED	Semaglutide + Firsocostat 20 mg + Cilofexor 30 mg	19
Overall Study	NOT COMPLETED	Semaglutide	3
Overall Study	NOT COMPLETED	Semaglutide + Firsocostat 20 mg	2
Overall Study	NOT COMPLETED	Semaglutide + Cilofexor 30 mg	1
Overall Study	NOT COMPLETED	Semaglutide + Cilofexor 100 mg	4
Overall Study	NOT COMPLETED	Semaglutide + Firsocostat 20 mg + Cilofexor 30 mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03987074/flow